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Comparative Effects of Diazepam and Midazolam on 
Paraoxon Toxicity in Rats’** 
Comparative Effects of Diaxepam and Midazolam on Paraoxon Toxicity in Rats. KRUTAK- 
KROL, H., AND DOMINO, E. F. (1985). Toxicol. Appl. Pharmacol. 81,545-550. The present study 
was undertaken to compare the effectiveness of a new water-soluble benzodiazepine, midazolam, 
to diazepam, both administered im for protection against diethyl-pnitrophenyl phosphate (para- 
oxon) toxicity. Adult male Sprague-Dawley rats were pretreated with midazolam or diazepam 
(0.32-32.0 mgkg) alone or in combination with atropine (10.0 mg/kg). Twenty minutes later 
2~ LD50 of paraoxon was injected sc and the incidence of seizures and death were recorded for 
24 hr. In another series of experiments, the LD50 of paraoxon was evaluated in the rats pretreated 
im with atropine (10.0 mgkg) and midaxolam or diazepam (10.0 mg/kg). Pretreatment with 
atropine alone did not prevent paraoxon-induced seizures but did reduce mortality. Both ben- 
zodiazepines were very effective alone or when combined with atropine in reducing the incidence 
of paraoxon-induced seizures. When given alone, neither benzodiazepine protected against para- 
oxon-induced mortality. However, when combined with atropine both benzodiazepines dramat- 
ically decreased the lethality of 2X LD50 of paraoxon. In equal doses given im, midazolam proved 
to be more potent than diazepam. Q 1985 Academic Press, Inc. 
It is generally accepted that inhibition of ace- 
tylcholinesterase (AChE) results in an accu- 
mulation of acetylcholine (ACh) which may 
be responsible for the acute toxic effects of or- 
ganophosphorous (OP) compounds. Although 
atropine has long been used in the treatment 
of poisoning by acetylcholinesterase inhibitors 
(AChEI), including OP agents, it does not sig- 
nificantly reduce convulsions nor does it dras- 
tically alter their LD50 values. Inasmuch as 
antimuscarinic and ganglionic blocking agents 
alone or together do not provide sufficient an- 
tidotal activity against OP AChEIs, it follows 
that ACh may not be the only transmitter in- 
volved in their CNS actions. OP-induced con- 
vulsions may be related to reduced effective- 
ness of y-aminobutyric acid (GABA) in the 
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Chemical Defense Bioscience Review sponsored by the 
U.S. Army Medical Research Insitute of Chemical Defense, 
Columbia, Md. and at the International Meeting “Neu- 
robiology of Acetylcholine,” Loyola University, Chicago, 
Ill. 
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search Fund (Domino) and the U.S. Army Medical Re- 
search and Development Command Contract DAMD 17- 
84-C-4157. 
brain (Kar and Matin, 1972; Matin and Kar, 
1973; Lundy et al., 1978). Further studies on 
the detailed mechanisms involving GABA still 
need to be done. 
Recent in vitro and in vivo studies (Haefely 
et al., 198 1; Meldrum and Braestrup, 1983) 
have shown that benzodiazepines enhance the 
postsynaptic inhibitory actions of GABA (both 
exogenous and synaptically released). Indeed, 
benzodiazepines are the most potent of the 
clinically available anticonvulsants, particu- 
lary when seizures are chemically induced by 
a large variety of substances. At least five re- 
ports have suggested that diazepam is poten- 
tially useful as an antidote against poisoning 
by AChEI (Lipp, 1972, 1973; Rump et al., 
1973; Johnson and Lowndes, 1974; Johnson 
and Wilcox, 1975). However, significant dis- 
advantages are associated with the im admin- 
istration of diazepam. The im use of this com- 
pound has almost disappeared from clinical 
practice (Reves et al., 1984) because the drug 
is poorly absorbed, the injection is painful, and 
there is considerable local irritation. Therefore, 
evaluation of the anticonvulsant activity of 
novel, water soluble benzodiazepines such as 
midazolam is necessary. In general, midazo- 
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lam, which shares the common pharmaco- 
dynamic properties and mechanisms of action 
with all benzodiazepines, has a shorter dura- 
tion of action than does diazepam but is more 
potent. With regard to central nervous system 
GABA receptor binding, midazolam has a 
fivefold greater affinity than does diazepam 
(Mohler and Okada, 1977). Midazolam ap- 
pears to be an ideal compound for im injec- 
tion. After adminstration of the water-soluble 
preparation, the midazolam ring closes, caus- 
ing the drug to become highly lipid soluble 
and to rapidly cross the blood brain barrier. 
The present study was initiated to determine 
if midazolam had any advantages over diaze- 
pam in the treatment of paraoxon toxicity in 
an animal model. 
METHODS 
A total of 550 adult male Sprague-Dawley (Harlan Inc., 
Indianapolis, Ind.) rats, 250 to 404 g, were used in these 
experiments. They were maintained on a Purina rodent 
chow diet and were allowed free access to feed and water 
except during the time they were removed from their cages 
for testing. In general, there were five animals per cage. 
Subsequently, at the time of the experiment each animal 
was placed in its own cage. All experiments were performed 
between 9:00 to 11:OO AM since it has been previously 
shown that maximal sensitivity to seizures occurs during 
this period (Davis and Webb, 1963). All tested compounds 
were administered in a concentration that would keep the 
volume of the injection solution constant ( 1 ml/kg). Atro- 
pine and midazolam were dissolved in 0.9% NaCl im- 
mediately before injections. Drug doses were calculated 
as free base. Sources of the agents used were: atropine 
sulfate (Sigma Chemical Co., St. Louis, MO. 63178), di- 
azepam commercial solution (m propylene glycol + 10% 
ethyl alcohol in water) and midazolam maleate (Hofhnan- 
LaRoche Inc., Nutley, N.J. 071 lo), and paraoxon (Sigma). 
Study A. Gross behavioral changes and toxic symptoms 
induced by paraoxon were evaluated. Animals were in- 
jected sc with paraoxon in a dose range of 0.032-l .O mg/ 
kg. In these and subsequent experiments the rats were ex- 
amined visually for toxic symptoms such as initial changes 
in activity (calmness, hyperexcitability, sleep, stupor), sal- 
ivation, lacrimation, piloerection, eyeball protrusion (ex- 
ophthalmos), and evidence of respiratory distress. Ataxia, 
sensory evoked hyperactivity, tremor, jerks, and general- 
ized convulsions were recorded. The type of seizure was 
analyzed as tonic (tlexor and/or extensor) or clonic: mild, 
moderate (convulsions up to 5 set), and severe (convulsed 
repeatedly for more than 5 set). Recovery or death within 
24 hr was evaluated. The mean convulsant dose 50% 
(CD50), the mean lethal dose 50% (LD50), and the 95% 
confidence limits were calculated by the method of Litch- 
field and Wilcoxon with an IMB PC computer (Tallarida 
and Murray, 198 1). 
Study B. Two series of experiments were undertaken. 
(1) Varying doses of atropine, diazepam, and midazolam 
alone or in combination were evaluated against 2X LDSO 
of paraoxon sc. Groups of eight rats at a minimum of five 
logarithmic doses of diazepam or midazolam (0.32-32.0 
mg/kg) and atropine (1 .O-100.0 mg/kg) were used. Both 
compounds were given im since this is the most practical 
and rapid route of antidote administration. Pretreatment 
time (20 min) prior to paraoxon was based on data con- 
cerning absorption and peak plasma concentrations of 
midazolam following its im administration to humans. 
The control group of animals were pretreated with 0.9% 
NaCl (saline) or 40% propylene glycol + 10% ethyl alcohol 
in water. 
(2). The LDSOs of sc paraoxon were evaluated in rats 
pretreated with atropine ( 10.0 m& im), midazolam (10.0 
mg/kg, im), and/or diazepam (10.0 mg/k& im). The pre- 
treatment time and route of drug injections were as above. 
RESULTS 
Study A 
The sc administration of low doses (0.032- 
0.10 mg/kg) of paraoxon to rats induced slight 
gross behavioral changes like grooming, 
chewing, sniffing, and piloerection. A dose 
of 0.032 mg/kg caused (within 3-5 min) 
signs of cholinergic poisoning such as lacri- 
mation, salivation, exophthalmos, fascicula- 
tions, tremor, and respiratory distress (brad- 
ypnea and dyspnea). Thirty percent of the an- 
imals developed moderate clonic seizures with 
a mild tonic component. Sixteen percent of 
the rats given a dose of 0.32 mg/kg died within 
15-20 min. Adminstration of a larger dose ( 1 .O 
mg/kg) produced immediate toxic signs: 
tremor, jerks, and severe respiratory depres- 
sion. All of these animals developed clonic 
seizures lasting 2-4 min until they died. Mor- 
tality in this group of rats was 100%. 
The CD50 of paraoxon was determined to 
be 0.35 mg/kg with 95% confidence limits of 
0.25-0.48. The LD50 calculated from the data 
was 0.38 mg/kg with 95% confidence limits of 
0.27-0.52. 
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FIG. 1. Comparative effects of atropine, diazepam, and midazolam alone on paraoxon-induced seizures. 
The rats were pretreated with single, varying doses of ktropine, diazepam, or midazolam given im. Twenty 
minutes later the animals were challenged with 2X LD50 (0.76 mg/kg) of paraoxon sc. 
Study B 
1. Effect of atropine alone on paraoxon 
toxicity. These results are summarized in Figs. 
1 and 2. Rats (eight per group) were pretreated 
with im atropine in single doses ( 1 .O, 3.2, 10.0, 
32.0, and 100.0 mg/kg) 20 min prior to the SC 
administration of paraoxon (0.76 mg/kg = 2X 
LD50). The best protective effect against death 
was achieved by a 10.0 mg/kg dose of atropine 
(Fig. 1). Therefore, this dose was selected for 
subsequent experiments. Larger doses of atro- 
pine (32.0-100.0 mg/kg) increased mortality 
slightly compared to the 10.0 mg/kg dose. 
Pretreatment with atropine did not prevent 
paraoxon-induced seizures. However, it de- 
creased salivation, lacrimation, and respiratory 
distress. 
2. Efict of midazolam alone. In these series 
of experiments, rats (eight per group) were in- 
jected with midazolam im in single doses 
(0.32, 1.0, 3.20, 10.0, and 32.0, mg/kg). Low 
doses of midazolam produced no obvious ef- 
fect. 
With larger doses (3.2-10.0 mg/kg) rapid 
absorption of midazolam from the im injec- 
tion was apparent after 2-3 min (i.e., rats be- 
came calm). By 5 min, all of the animals 
showed skeletal muscle relaxation and some 
developed ataxia but none fell asleep. A dose 
of 32.0 mg/kg of midazolam produced an 
anesthesia like state. 
3. Efect of midazolam pretreatment on 
paraoxon toxicity. The incidence of paraoxon- 
induced convulsions was signScantly reduced 
by prior adminstration of midazolam (Fig. 1). 
Doses of 3.2-10.0 mg/kg produced 75-80% 
protection against seizures produced by 2X 
LD50 of paraoxon. However, midazolam 
alone only slightly prevented death (Fig. 2). 
Pretreatment with both atropine (10.0 mg/kg) 
and midazolam (0.32-32.0 mg/kg) produced 
100% protection against death. The combi- 
nation of atropine ( 10.0 mg/kg) and midazo- 
lam (10.0 mg/kg) increased the LD50 of para- 
oxon to 4.12 (2.50-6.8 1 mg/kg, see Table 1). 
This pretreatment regime provided a protec- 
tive ratio of 11.0. 
4. E$ets of diazepam alone. In another se- 
ries of experiments, the effect of diazepam in 
single doses im was tested. Low doses (0.32- 
3.2 mg/kg) produced no obvious effect. With 
larger doses (10.0 mg/kg) the animal showed 
skeletal muscle relaxation and some developed 
ataxia. A dose of 32.0 mg/kg of diazepam in- 
duced an anesthesia like state. A delay of lo- 
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FIG. 2. Comparative effects of atropine, diazepam, and midazolam alone on paraoxon-induced death. 
The experimental procedure was as described in Fig. I. 
15 min from injection to occurrence of the 
first signs was seen. 
5. Efects of diazepam pretreatment on 
paraoxon toxicity. In diazepam-pretreated 
animals there was a dosedependent reduction 
in paraoxon-induced convulsions (Fig. 1). 
Small doses of diazepam (0.32- 1 .O mg/kg) had 
no anticonvulsant activity. A dose of 32.0 mg/ 
kg reduced convulsions by 25%. Doses of di- 
azepam from 10.0 to 32.0 mg/kg provided 
7 1.8- 100% protection against seizures. How- 
ever, diazepam alone, even in a very large dose 
(32.0 mg/kg), did not prevent paraoxon-in- 
duced respiratory distress and death (Fig. 2). 
Pretreatment with both atropine (10.0 mg/kg) 
and diazepam (10.0 mg/kg) provided 100% 
protection against death. 
The combination of atropine ( 10.0 mg/kg) 
and diazepam (10.0 mg/kg) increased the 
LD50 of paraoxon to 2.72 (1.73428) mg/kg 
(Table 1). This pretreatment regime provided 
a protective ratio of 7.16. 
DISCUSSION 
The manifestations of OP AChEI toxicity 
include hypersecretion, motor hyperactivity, 
fasciculations, convulsions, respiratory dis- 
tress, and death. The cause of death has been 
attributed to both central and peripheral re- 
spiratory depression. Atropine showed a ben- 
eficial effect on impaired respiration caused 
by paraoxon and increased the LD50 by a fac- 
tor of 3.1. The present studies confirm the 










Atropine 10.0 mg/kg 
Diazepam 10.0 mg/kg 
Midazolam 10.0 mgFg 
Diazepam 10 mg/kg 
+ atropine 10.0 mg/kg 
Midazolam 10.0 mg/kg 
+ atropine 10.0 mg/kg 
73 0.38 (0.27-0.52) 
25 0.33 (0.21-0.52) 
32 1.18 (0.97-1.42) 
43 0.35 (0.13-0.92) 
61 0.57 (0.29-1.12) 
83 2.72 (1.73-4.28) 
72 4.17 (2.50-6.81) 
“Dosesofparaoxonusedwere:0.76, 1.0, 1.52,2.0,3.0, 
4.0, 6.0 mg/kg. 
* Atropine and midazolam or diazepam were injected 
im 20 min prior to the SC administration of paraoxon. 
r Number of animals used. 
to OP-induced respiratory failure (Johnson potentiation of the inhibitory effect of GABA 
and Wilcox, 1975; Lipp, 1976). Atropine ap- (Cheng and Brunner, 198 1). Since midazolam 
pears to have at least three mechanisms of ac- is effective in suppressing paraoxon-induced 
tion in reducing respiratory depression: (1) it seizures, one can conclude that enhancement 
blocks the interaction between ACh and cho- of GABA mechanisms reduces paraoxon-in- 
linergic receptors in the central respiratory duced seizures. Perhaps paraoxon induces sei- 
center, (2) it reduces tracheobronchial secre- zures by a non-cholinergic mechanism related 
tion, and (3) it increases the heart rate which to inhibition of GABA. Of course, the other 
possibly enhances blood flow to the brainstem possibility remains that paraoxon-induced 
respiratory centers, thus reducing the anoxia convulsions are mediated through the release 
which results in activation of respiratory neu- of an excitatory transmitter such as glutamate, 
rons (Lipp, 1976). However, atropine, when etc, in the brain which is affected by benzo- 
injected alone, does not antagonize seizures diazepines directly or indirectly. 
induced by paraoxon. We hypothesized that In the present study, both benzodiazepines 
if the convulsions produced by paraoxon (and were very effective when combined with atro- 
probably other OP agents) were solely a result pine in reducing the incidence of paraoxon- 
of activation of the cholinergic system, high induced seizures and dramatically reducing the 
doses of atropine would have abolished the lethality of 2X LDSO of paraoxon. However, 
convulsions, since an-opine pretreatment pre- midazolam was more potent on a milligram 
vents paraoxon-induced increases in brain per kilogram basis. 
ACh amounts (Wecker et al., 1977). Large In atropine/midazolam-pretreated animals, 
doses (32.0-100.0 mg/kg) of atropine did not the LD50 of paraoxon was increased by a fac- 
antagonize paraoxon-induced seizures and tor of 11.0. Diazepam, when combined with 
were less effective in protecting against death atropine, increased the LD50 of paraoxon by 
than smaller doses (10.0 mg/kg) of atropine. 7.16. When given im to humans, midazolam 
Since atropine does not provide complete is better absorbed than is diazepam. Midazo- 
protection against OP poisoning, other forms lam, contrary to the present commercial di- 
of therapy have been investigated. Benzodi- azepam solution, is compatible when mixed 
azepines have been reported to provide both with other agents in the same syringe. Thus, 
protective and antidotal activity against poi- midazolam would be preferred in treating 
soning by OP AChEI (Lipp, 1972,1973,1974; paraoxon poisoning, assuming that the tat data 
Rump et al., 1973; Johnson and Lowndes, are applicable to humans. 
1974; Lundy et al., 1978; Jones et al., 1984). 
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